(PDF) Adoptive Immunotherapy of BCR-ABL-induced Chronic

Adoptive Immunotherapy of BCR-ABL-induced Chronic Myeloid Leukemia-Like Myeloproliferative Disease in a Murine Model

Blood - United States

doi 10.1182/blood-2004-06-2229

Full Text

Abstract

Available in full text

Categories

Date

December 15, 2004

Authors

Daniela S. Krause

Richard A. Van Etten

Publisher

American Society of Hematology

Related search

Combined Inhibition of MDM2 and BCR-Abl Tyrosine Kinase Targets Chronic Myeloid Leukemia Stem/Progenitor Cells in a Murine Model

English

Acute Myeloid Leukemia With BCR/ABL Fusion Chimera

Indian Journal of Hematology and Blood Transfusion

English

IL-3 Receptor Signaling Is Dispensable for BCR-ABL-induced Myeloproliferative Disease

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

English

The Grb2 Binding Site Is Required for the Induction of Chronic Myeloid Leukemia-Like Disease in Mice by the BCR/Abl Tyrosine Kinase

English

The Grb2 Binding Site Is Required for the Induction of Chronic Myeloid Leukemia-Like Disease in Mice by the BCR/Abl Tyrosine Kinase

English

Inhibitory Effects of Omacetaxine on Leukemic Stem Cells and BCR-ABL-induced Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia in Mice

Cancer Research

English

Management of Chronic Myeloid Leukemia With BCR/ABL Inhibitors: Current Status and Future Perspectives

Clinical Medicine Insights: Therapeutics

Pharmaceutical Science

English

Fluorescent In-Situ Hybridization (FISH) for BCR/ABL in Chronic Myeloid Leukemia After Bone Marrow Transplantation

Sao Paulo Medical Journal

English

Chronic Myeloid Leukemia With an E1a3 BCR-ABL Fusion Protein: Transformation to Lymphoid Blast Crisis

Biomarker Research

Molecular Medicine

Clinical Biochemistry

English